Enxaqueca na gravidez: uma revisão integrativa

Views: 80

Autores

DOI:

https://doi.org/10.48208/HeadacheMed.2025.35

Palavras-chave:

Enxaqueca, Gravidez, Pós-parto, Amamentação, Complicações fetais

Resumo

Contexto

A enxaqueca é a cefaleia primária mais prevalente na gravidez, com implicações clínicas únicas que exigem abordagens de manejo especializadas.

Objetivo

Fornecer uma revisão abrangente da fisiopatologia, curso clínico, diagnóstico e manejo da enxaqueca durante a gravidez, o pós-parto e a lactação.

Métodos

Busca seletiva de literatura nas bases de dados PubMed, Scopus e Web of Science, complementada por ferramentas de inteligência artificial (Elicit e Consensus) para garantir a cobertura abrangente de evidências emergentes, de 2003 a 2025.

Principais Resultados

As flutuações hormonais impulsionam a fisiopatologia da enxaqueca, sendo que a estabilidade hormonal da gravidez geralmente melhora os sintomas em 60-70% das mulheres com enxaqueca sem aura durante o segundo e terceiro trimestres. No entanto, a enxaqueca com aura apresenta melhora menos previsível e podem ocorrer novos ataques. A enxaqueca materna, particularmente com aura, está associada a distúrbios hipertensivos, parto prematuro, parto cesáreo, restrição do crescimento fetal e aumento do risco de acidente vascular cerebral isquêmico. Comorbidades psiquiátricas, incluindo depressão e ansiedade, são frequentes e associadas a piores desfechos.

Manejo

Intervenções não farmacológicas constituem a base do tratamento. Quando a terapia farmacológica é necessária, o paracetamol é a primeira opção, os AINEs podem ser usados ​​apenas no segundo trimestre e o sumatriptano é a opção mais segura entre os triptanos. O tratamento preventivo deve ser reservado para casos graves e refratários, com magnésio, propranolol e amitriptilina como opções baseadas em evidências.

Conclusão

A enxaqueca durante a gravidez e o pós-parto requer uma abordagem multidisciplinar que priorize estratégias farmacológicas seguras, monitoramento individualizado e otimização do estilo de vida para garantir os melhores resultados maternos e fetais.

Downloads

Não há dados estatísticos.

Referências

1. Kim S, Park JW. Migraines in Women: A Focus on Reproductive Events and Hormonal Milestones. Headache and Pain Research 2024;25:3–15. Doi:10.62087/hpr.2024.0003.

2. Burch R. Epidemiology and Treatment of Menstrual Migraine and Migraine During Pregnancy and Lactation: A Narrative Review. Headache: The Journal of Head and Face Pain 2020;60:200–16. Doi:10.1111/head.13665.

3. Saldanha IJ, Cao W, Bhuma MR, Konnyu KJ, Adam GP, Mehta S, et al. Management of primary headaches during pregnancy, postpartum, and breastfeeding: A systematic review. Headache: The Journal of Head and Face Pain 2021;61:11–43. Doi:10.1111/head.14041.

4. Phillips K, Koonalintip P, Wakerley BR. Migraine and Pregnancy. Life 2024;14:1224. Doi:10.3390/life14101224.

5. Sances G, Granella F, Nappi R, Fignon A, Ghiotto N, Polatti F, et al. Course of Migraine During Pregnancy and Postpartum: A Prospective Study. Cephalalgia 2003;23:197–205. Doi:10.1046/j.1468-2982.2003.00480.x.

6. Kvisvik EV, Stovner LJ, Helde G, Bovim G, Linde M. Headache and migraine during pregnancy and puerperium: the MIGRA-study. J Headache Pain 2011;12:443–51. Doi:10.1007/s10194-011-0329-1.

7. Paškevičiūtė E, Bužinskienė D, Ryliškienė K. De novo migraine with aura in the third trimester of pregnancy: a case report and literature review. Acta Med Litu 2021;28:145–52. Doi:10.15388/Amed.2021.28.1.19.

8. Tiseo C, Vacca A, Felbush A, Filimonova T, Gai A, Glazyrina T, et al. Migraine and sleep disorders: a systematic review. J Headache Pain 2020;21:126. Doi:10.1186/s10194-020-01192-5.

9. Deneris A, Rosati Allen P, Hart Hayes E, Latendresse G. Migraines in Women: Current Evidence for Management of Episodic and Chronic Migraines. J Midwifery Womens Health 2017;62:270–85. Doi:10.1111/jmwh.12626.

10. Khan J, Asoom LI Al, Sunni A Al, Rafique N, Latif R, Saif S Al, et al. Genetics, pathophysiology, diagnosis, treatment, management, and prevention of migraine. Biomedicine & Pharmacotherapy 2021;139:111557. Doi:10.1016/j.biopha.2021.111557.

11. Barus J, Sudharta H, Adriani D. Study of the Mechanisms and Therapeutic Approaches of Migraine in Women and Pregnancy: A Literature Review. Cureus 2023. Doi:10.7759/cureus.35284.

12. Allais G, Chiarle G, Sinigaglia S, Airola G, Schiapparelli P, Benedetto C. Gender-related differences in migraine. Neurological Sciences 2020;41:429–36. Doi:10.1007/s10072-020-04643-8.

13. Godley F, Meitzen J, Nahman-Averbuch H, O’Neal MA, Yeomans D, Santoro N, et al. How Sex Hormones Affect Migraine: An Interdisciplinary Preclinical Research Panel Review. J Pers Med 2024;14:184. Doi:10.3390/jpm14020184.

14. Lackovic M, Jankovic M, Mihajlovic S, Milovanovic Z, Nikolic D. Exploring the Connection between Migraines and Pregnancy: The Impact of Physical Activity on Symptom Management. Medicina (B Aires) 2023;60:49. Doi:10.3390/medicina60010049.

15. Susanti R, Muhammad S. Migraine And Pregnancy: What Should We Know. Andalas Obstetrics And Gynecology Journal 2020;4:251–60. Doi:10.25077/aoj.4.2.251-260.2020.

16. Munoz-Ceron J, Marin-Careaga V, Peña L, Mutis J, Ortiz G. Headache at the emergency room: Etiologies, diagnostic usefulness of the ICHD 3 criteria, red and green flags. PLoS One 2019;14:e0208728. Doi:10.1371/journal.pone.0208728.

17. Cigarán-Mendez M, Pacho-Hernández JC, Fernández-Palacios FG, Tejera-Alonso Á, Valera-Calero JA, Gómez-Calero C, et al. Can Clinical, Psychophysical or Psychological Variables Help in Discriminating Women with Migraines from a Tertiary Center? A Diagnostic Accuracy Study. Diagnostics 2024;14:2805. Doi:10.3390/diagnostics14242805.

18. Magro I, Nurimba M, Doherty JK. Headache in Pregnancy. Otolaryngol Clin North Am 2022;55:681–96. Doi:10.1016/j.otc.2022.02.013.

19. Robbins MS, Farmakidis C, Dayal AK, Lipton RB. Acute headache diagnosis in pregnant women. Neurology 2015;85:1024–30. Doi:10.1212/WNL.0000000000001954.

20. Chansakul T, Young G. Neuroimaging in Pregnant Women. Semin Neurol 2017;37:712–23. Doi:10.1055/s-0037-1608939.

21. Haghdoost F, Togha M. Migraine management: Non-pharmacological points for patients and health care professionals. Open Medicine 2022;17:1869–82. Doi:10.1515/med-2022-0598.

22. Ghadiri-Sani M. Migraine in women: a review. Curr Opin Neurol 2025;38:271–6. Doi:10.1097/WCO.0000000000001372.

23. Smirnoff L, Bravo M, Hyppolite T. Neuromodulation for Headache Management in Pregnancy. Curr Pain Headache Rep 2025;29:14. Doi:10.1007/s11916-024-01344-1.

24. Parikh S, Delbono M, Silberstein S. Managing migraine in pregnancy and breastfeeding, 2020, p. 275–309. Doi:10.1016/bs.pbr.2020.07.011.

25. Puledda F, Sacco S, Diener H-C, Ashina M, Al-Khazali HM, Ashina S, et al. International Headache Society global practice recommendations for the acute pharmacological treatment of migraine. Cephalalgia 2024;44. Doi:10.1177/03331024241252666.

26. Nezvalová‐Henriksen K, Spigset O, Nordeng H. Triptan Exposure During Pregnancy and the Risk of Major Congenital Malformations and Adverse Pregnancy Outcomes: Results From The Norwegian Mother and Child Cohort Study. Headache: The Journal of Head and Face Pain 2010;50:563–75. Doi:10.1111/j.1526-4610.2010.01619.x.

27. González-García N, Díaz de Terán J, López-Veloso AC, Mas-Sala N, Mínguez-Olaondo A, Ruiz-Piñero M, et al. Cefalea: embarazo y lactancia. Recomendaciones del Grupo de Estudio de Cefaleas de la Sociedad Española de Neurología (GECSEN). Neurología 2022;37:1–12. Doi:10.1016/j.nrl.2018.12.003.

28. Spiteri JA, Camilleri G, Piccinni C, Sultana J. Safety of drugs used for the treatment of migraine during pregnancy: a narrative review. Expert Rev Clin Pharmacol 2023;16:207–17. Doi:10.1080/17512433.2023.2181157.

29. Turankar T, Sorte A, Wanjari MB, Chakole S, Sawale S. Relation and Treatment Approach of Migraine in Pregnancy and Breastfeeding. Cureus 2023. Doi:10.7759/cureus.36828.

30. Stern JI, Chiang C, Kissoon NR, Robertson CE. Narrative review of peripheral nerve blocks for the management of headache. Headache: The Journal of Head and Face Pain 2022;62:1077–92. Doi:10.1111/head.14385.

31. Wahab S, Kataria S, Woolley P, O’Hene N, Odinkemere C, Kim R, et al. Literature Review: Pericranial Nerve Blocks for Chronic Migraines. Health Psychol Res 2023;11:1. Doi:10.52965/001c.74259.

32. Naghdi S, Underwood M, Madan J, Brown A, Duncan C, Matharu M, et al. Clinical effectiveness of pharmacological interventions for managing chronic migraine in adults: a systematic review and network meta-analysis. J Headache Pain 2023;24:164. Doi:10.1186/s10194-023-01696-w.

33. Brin MF, Kirby RS, Slavotinek A, Adams AM, Parker L, Ukah A, et al. Pregnancy Outcomes in Patients Exposed to OnabotulinumtoxinA Treatment. Neurology 2023;101. Doi:10.1212/WNL.0000000000207375.

34. Russo A, Iannone LF, Orologio I, Rivi V, Boccalini A, Lo Castro F, et al. Safety of Onabotulinumtoxin-A for Chronic Migraine During Pregnancy and Breastfeeding: A Narrative Review. Toxins (Basel) 2025;17:192. Doi:10.3390/toxins17040192.

35. Buse DC, Reed ML, Fanning KM, Bostic R, Dodick DW, Schwedt TJ, et al. Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) study. J Headache Pain 2020;21:23. Doi:10.1186/s10194-020-1084-y.

36. Welander NZ, Mwinyi J, Asif S, Schiöth HB, Skalkidou A, Fransson E. Migraine as a risk factor for mixed symptoms of peripartum depression and anxiety in late pregnancy: A prospective cohort study. J Affect Disord 2021;295:733–9. Doi:10.1016/j.jad.2021.08.119.

37. Reis ACS dos S e, Gonçalves ALR, Santos BOR dos, Silva JMP e, Câmara L de ÁGCD, Jurno ME. Prevalence of postpartum depression in patients with migraine. Headache Medicine 2022;13:222–5. Doi:10.48208/HeadacheMed.2022.24.

38. Hoshiyama E, Tatsumoto M, Iwanami H, Saisu A, Watanabe H, Inaba N, et al. Postpartum Migraines: A Long-term Prospective Study. Internal Medicine 2012;51:3119–23. Doi:10.2169/internalmedicine.51.8542.

39. Amundsen S, Nordeng H, Nezvalová-Henriksen K, Stovner LJ, Spigset O. Pharmacological treatment of migraine during pregnancy and breastfeeding. Nat Rev Neurol 2015;11:209–19. Doi:10.1038/nrneurol.2015.29.

40. Faubion SS, Batur P, Calhoun AH. Migraine Throughout the Female Reproductive Life Cycle. Mayo Clin Proc 2018;93:639–45. Doi:10.1016/j.mayocp.2017.11.027.

41. Chalmer MA, Kogelman LJA, Ullum H, Sørensen E, Didriksen M, Mikkelsen S, et al. Population-Based Characterization of Menstrual Migraine and Proposed Diagnostic Criteria. JAMA Netw Open 2023;6:e2313235. Doi:10.1001/jamanetworkopen.2023.13235.

42. Wells RE, Turner DP, Lee M, Bishop L, Strauss L. Managing Migraine During Pregnancy and Lactation. Curr Neurol Neurosci Rep 2016;16:40. Doi:10.1007/s11910-016-0634-9.

43. Gordon-Smith K, Ridley P, Perry A, Craddock N, Jones I, Jones L. Migraine associated with early onset postpartum depression in women with major depressive disorder. Arch Womens Ment Health 2021;24:949–55. Doi:10.1007/s00737-021-01131-6.

44. Marmura MJ. Triggers, Protectors, and Predictors in Episodic Migraine. Curr Pain Headache Rep 2018;22:81. Doi:10.1007/s11916-018-0734-0.

45. Parikh SK. Unique Populations with Episodic Migraine: Pregnant and Lactating Women. Curr Pain Headache Rep 2018;22:80. Doi:10.1007/s11916-018-0737-x.

46. Charles A. Migraine. New England Journal of Medicine 2017;377:553–61. Doi:10.1056/NEJMcp1605502.

47. Seng EK, Gosnell I, Sutton L, Grinberg AS. Behavioral Management of Episodic Migraine: Maintaining a Healthy Consistent Lifestyle. Curr Pain Headache Rep 2022;26:247–52. Doi:10.1007/s11916-022-01023-z.

48. Robblee J, Starling AJ. SEEDS for success: Lifestyle management in migraine. Cleve Clin J Med 2019;86:741–9. Doi:10.3949/ccjm.86a.19009.

49. Agbetou M, Adoukonou T. Lifestyle Modifications for Migraine Management. Front Neurol 2022;13. Doi:10.3389/fneur.2022.719467.

50. Airola G, Allais G, Castagnoli Gabellari I, Rolando S, Mana O, Benedetto C. Non-pharmacological management of migraine during pregnancy. Neurological Sciences 2010;31:63–5. Doi:10.1007/s10072-010-0276-7.

51. Qaseem A, Tice JA, Etxeandia-Ikobaltzeta I, Wilt TJ, Harrod CS, Cooney TG, et al. Pharmacologic Treatments of Acute Episodic Migraine Headache in Outpatient Settings: A Clinical Guideline From the American College of Physicians. Ann Intern Med 2025;178:571–8. Doi:10.7326/ANNALS-24-03095.

52. Bushnell C, McCullough LD, Awad IA, Chireau M V., Fedder WN, Furie KL, et al. Guidelines for the Prevention of Stroke in Women. Stroke 2014;45:1545–88. Doi:10.1161/01.str.0000442009.06663.48.

53. Gazerani P, Papetti L, Dalkara T, Cook CL, Webster C, Bai J. The Brain, the Eating Plate, and the Gut Microbiome: Partners in Migraine Pathogenesis. Nutrients 2024;16:2222. Doi:10.3390/nu16142222.

54. Razeghi Jahromi S, Ghorbani Z, Martelletti P, Lampl C, Togha M. Association of diet and headache. J Headache Pain 2019;20:106. Doi:10.1186/s10194-019-1057-1.

55. Roldán-Ruiz A, Bertotti G, López-Moreno M. Effects of Dietary Interventions in Patients With Migraine: A Systematic Review. Nutr Rev 2025;83:e1815–27. Doi:10.1093/nutrit/nuae188.

56. Moskatel LS, Zhang N. Migraine and Diet: Updates in Understanding. Curr Neurol Neurosci Rep 2022;22:327–34. Doi:10.1007/s11910-022-01195-6.

57. Tu Y-H, Chang C-M, Yang C-C, Tsai I-J, Chou Y-C, Yang C-P. Dietary Patterns and Migraine: Insights and Impact. Nutrients 2025;17:669. Doi:10.3390/nu17040669.

58. Altamura C, Cecchi G, Bravo M, Brunelli N, Laudisio A, Di Caprio P, et al. The Healthy Eating Plate Advice for Migraine Prevention: An Interventional Study. Nutrients 2020;12:1579. Doi:10.3390/nu12061579.

Downloads

Publicado

2026-01-01

Como Citar

1.
María Karina, Schubaroff P, Cid-Jeffs ML, Mercedes-Robles A, Martinez-Mayorga AP, Rodriguez-Leyva I, et al. Enxaqueca na gravidez: uma revisão integrativa. Headache Med [Internet]. 1º de janeiro de 2026 [citado 7º de janeiro de 2026];16(4):209-23. Disponível em: https://www.headachemedicine.com.br/index.php/hm/article/view/1373

Edição

Seção

Revisões